Close Menu

As part of its plan to promote its anti-cholesterol drug Vytorin, Merck and Schering-Plough paid 16 physicians, 14 of whom hold academic appointments, more than $450,000 for consulting and giving talks, reports the Chronicle of Higher Education. In this article, the Chronicle lists the physicians and the money they received.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.